Published in World J Gastroenterol on January 07, 2007
Microvesicles and viral infection. J Virol (2011) 2.10
Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J (2012) 1.75
Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol (2010) 1.59
Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci U S A (2007) 1.49
Molecular biology of hepatitis B virus infection. Virology (2015) 1.47
Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol (2007) 1.32
Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology (2010) 1.32
A function essential to viral entry underlies the hepatitis B virus "a" determinant. J Virol (2009) 1.24
Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction. J Virol (2009) 1.23
Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. J Virol (2010) 1.17
DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids. J Virol (2009) 1.14
The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. J Virol (2010) 1.11
The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J Virol (2009) 1.05
Recent advances in hepatitis B virus research: a German point of view. World J Gastroenterol (2007) 1.03
HBV life cycle: entry and morphogenesis. Viruses (2009) 0.98
Electrostatic regulation of genome packaging in human hepatitis B virus. Biophys J (2009) 0.97
Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell Microbiol (2009) 0.96
Subviral particle release determinants of prototype foamy virus. J Virol (2008) 0.95
The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity. J Virol (2009) 0.90
Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope protein. J Virol (2011) 0.89
Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation. J Appl Genet (2010) 0.89
A structural model for duck hepatitis B virus core protein derived by extensive mutagenesis. J Virol (2007) 0.88
Functional surfaces of the hepatitis B virus capsid. J Virol (2009) 0.88
Overview of hepatitis B viral replication and genetic variability. J Hepatol (2016) 0.87
Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes. J Virol (2007) 0.87
Hepatitis B genotypes in iran. Mater Sociomed (2014) 0.87
Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment. J Virol (2013) 0.86
Hepatitis B virus large surface protein: function and fame. Hepatobiliary Surg Nutr (2015) 0.86
Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation. Plant Cell Rep (2012) 0.85
Disulfide bond formation contributes to herpes simplex virus capsid stability and retention of pentons. J Virol (2011) 0.85
The foamy virus Gag proteins: what makes them different? Viruses (2013) 0.85
Role of transmembrane domains of hepatitis B virus small surface proteins in subviral-particle biogenesis. J Virol (2012) 0.84
The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile. Med Microbiol Immunol (2010) 0.83
Involvement of ESCRT-II in hepatitis B virus morphogenesis. PLoS One (2014) 0.83
Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B. Biomed Res Int (2014) 0.82
A theoretical model for the dynamic structure of hepatitis B nucleocapsid. Biophys J (2011) 0.82
Hepatitis B virus surface antigen assembly function persists when entire transmembrane domains 1 and 3 are replaced by a heterologous transmembrane sequence. J Virol (2010) 0.82
Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation. Sci Rep (2015) 0.82
Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes. PLoS Pathog (2008) 0.81
Biological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model. Virol J (2012) 0.81
Functional analysis of hepatitis B virus pre-s deletion variants associated with hepatocellular carcinoma. J Biomed Sci (2012) 0.81
Role of human sec63 in modulating the steady-state levels of multi-spanning membrane proteins. PLoS One (2012) 0.81
Foamy virus budding and release. Viruses (2013) 0.81
Biological characteristics comparison of HBV rtA181T mutants with truncated or substituted HBsAg expression in vitro and in vivo model systems. Sci Rep (2016) 0.80
Hepatitis B virus infection: An insight into infection outcomes and recent treatment options. Virusdisease (2015) 0.80
The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects? Int J Mol Sci (2013) 0.80
Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection. J Virol (2015) 0.78
An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation. J Virol (2015) 0.77
A theoretical study of SRPK interaction with the flexible domains of hepatitis B capsids. Biophys J (2014) 0.76
Subviral Hepatitis B Virus Filaments, like Infectious Viral Particles, Are Released via Multivesicular Bodies. J Virol (2015) 0.76
Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence. Int J Mol Sci (2015) 0.76
Potent inhibition of late stages of hepadnavirus replication by a modified cell penetrating peptide. PLoS One (2012) 0.76
HBV secretion is regulated through the activation of endocytic and autophagic compartments mediated by Rab7 stimulation. J Cell Sci (2015) 0.76
Can engineered "designer" T cells outsmart chronic hepatitis B? Hepat Res Treat (2010) 0.76
Multiple antibody targets on herpes B glycoproteins B and D identified by screening sera of infected rhesus macaques with peptide microarrays. PLoS One (2014) 0.76
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro. Oncotarget (2017) 0.75
The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B. Int J Mol Sci (2016) 0.75
Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation. J Clin Transl Hepatol (2016) 0.75
Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule. World J Gastroenterol (2016) 0.75
Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B. Virol J (2017) 0.75
Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res (2016) 0.75
Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC Infect Dis (2016) 0.75
Bioinformatic Identification of Rare Codon Clusters (RCCs) in HBV Genome and Evaluation of RCCs in Proteins Structure of Hepatitis B Virus. Hepat Mon (2016) 0.75
Detection of Hepatitis B Virus Particles Released from Cultured Cells by Particle Gel Assay. Methods Mol Biol (2017) 0.75
Discovery and mechanistic study of benzamide derivatives that modulate hepatitis B virus capsid assembly. J Virol (2017) 0.75
Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell (1982) 16.71
Hepatitis B virus immunopathogenesis. Annu Rev Immunol (1995) 8.62
The protein network of HIV budding. Cell (2003) 7.82
Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature (1997) 7.32
Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol (1984) 6.90
Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription. Nature (1990) 5.68
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A (1987) 4.72
Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA. Proc Natl Acad Sci U S A (1982) 4.69
Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A (2002) 4.52
Viral late domains. J Virol (2002) 4.51
The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A (1991) 4.37
The crystal structure of the human hepatitis B virus capsid. Mol Cell (1999) 4.36
Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature (1997) 4.35
Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol (1990) 4.26
Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci U S A (1996) 4.02
Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J (1992) 3.78
Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell (1994) 3.75
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J Virol (1991) 3.31
Structural relationships between minor and major proteins of hepatitis B surface antigen. J Virol (1983) 3.09
Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science (1986) 3.01
Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry (1996) 3.00
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science (2003) 2.84
A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J Virol (1989) 2.72
Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol (1994) 2.62
The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol (1987) 2.49
Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46
Human hepatitis B vaccine from recombinant yeast. Nature (1984) 2.46
Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol (1992) 2.45
Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J (1994) 2.35
Weak protein-protein interactions are sufficient to drive assembly of hepatitis B virus capsids. Biochemistry (2002) 2.34
Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol (1986) 2.24
A domain of the hepadnavirus capsid protein is specifically required for DNA maturation and virus assembly. J Virol (1991) 2.19
Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol (1987) 2.18
Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J (1995) 2.05
Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum. Mol Cell Biol (1989) 2.05
Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis. J Virol (1996) 1.99
Hepatitis B virus capsid particles are assembled from core-protein dimer precursors. Proc Natl Acad Sci U S A (1992) 1.98
Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores. Structure (1995) 1.98
A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J (1994) 1.96
Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A (2003) 1.93
Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses. J Virol (1996) 1.93
Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA. Proc Natl Acad Sci U S A (1997) 1.90
Phosphorylation of the duck hepatitis B virus capsid protein associated with conformational changes in the C terminus. J Virol (1994) 1.88
Multiple functions of capsid protein phosphorylation in duck hepatitis B virus replication. J Virol (1994) 1.86
Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. J Virol (2000) 1.79
Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci U S A (1999) 1.79
Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus. J Virol (1983) 1.79
Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol (1994) 1.78
Structure of hepatitis B surface antigen. Correlation of subtype with amino acid sequence and location of the carbohydrate moiety. J Biol Chem (1982) 1.78
A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation. J Virol (1997) 1.78
The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol (1999) 1.76
A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc Natl Acad Sci U S A (2005) 1.72
Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J Virol (2004) 1.72
Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J Biol Chem (1982) 1.69
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol (2005) 1.68
The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences. J Virol (1990) 1.68
Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Virol (1987) 1.64
Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids. Proc Natl Acad Sci U S A (2005) 1.57
Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J Virol (1991) 1.56
Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol (1997) 1.56
A micromolar pool of antigenically distinct precursors is required to initiate cooperative assembly of hepatitis B virus capsids in Xenopus oocytes. J Virol (1993) 1.55
Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol (2003) 1.55
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology (1996) 1.55
A structural model for maturation of the hepatitis B virus core. Proc Natl Acad Sci U S A (2005) 1.55
Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J Virol (1995) 1.54
A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle. J Cell Biol (1994) 1.51
Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles. J Virol (1991) 1.51
Phosphorylation in the carboxyl-terminal domain of the capsid protein of hepatitis B virus: evaluation with a monoclonal antibody. J Virol (1991) 1.48
Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein. J Biol Chem (2003) 1.46
Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol (1993) 1.45
Dual topology of the hepatitis B virus large envelope protein: determinants influencing post-translational pre-S translocation. J Biol Chem (2001) 1.43
Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation. J Virol (2003) 1.42
Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol (2000) 1.41
Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. J Virol (2002) 1.40
Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle. Virology (1997) 1.36
The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology (1996) 1.32
Hepatitis B virus core gene mutations which block nucleocapsid envelopment. J Virol (2000) 1.31
The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J (2002) 1.29
Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins. J Virol (1991) 1.29
Hepatitis B small surface antigen particles are octahedral. Proc Natl Acad Sci U S A (2005) 1.25
Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis--associated antigen. Am J Med Sci (1972) 1.23
A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L). J Virol (2000) 1.22
The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern. J Biol Chem (1992) 1.22
Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J Virol (2002) 1.21
Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology (1995) 1.21
Intracellular hepadnavirus nucleocapsids are selected for secretion by envelope protein-independent membrane binding. J Virol (2000) 1.21
Topological analysis of the hepatitis B virus core particle by cysteine-cysteine cross-linking. J Mol Biol (1992) 1.20
Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus. Proc Natl Acad Sci U S A (1995) 1.19
Duck hepatitis B virus virion secretion requires a double-stranded DNA genome. J Virol (2003) 1.19
Formation of intracellular particles by hepatitis B virus large surface protein. J Virol (1997) 1.19
Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion. J Virol (2002) 1.18
Role of p50/CDC37 in hepadnavirus assembly and replication. J Biol Chem (2002) 1.17
Topology of the large envelope protein of duck hepatitis B virus suggests a mechanism for membrane translocation during particle morphogenesis. J Virol (1997) 1.17
Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res (1998) 1.17
Chaperone action in the posttranslational topological reorientation of the hepatitis B virus large envelope protein: Implications for translocational regulation. Proc Natl Acad Sci U S A (2003) 1.15
Dual topology of the large envelope protein of duck hepatitis B virus: determinants preventing pre-S translocation and glycosylation. J Virol (1997) 1.14
Characterization of early hepatitis B virus surface protein oligomers. Arch Virol (1996) 1.13